(Q40570310)

21 September 2017

1 reference

title

New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin (English)

1 reference

21 September 2017

0 references

1 reference

1

1 reference

21 September 2017

B Vazquez

2

1 reference

21 September 2017

D Luciano

series ordinal

3

1 reference

21 September 2017

publication date

1 October 1994

1 reference

Journal of Child Neurology

21 September 2017

published in

1 reference

21 September 2017

volume

9 Suppl 1

1 reference

21 September 2017

page(s)

S33-45

1 reference

Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modeling to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Felbamate for partial seizures: results of a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Gabapentin as an antiepileptic drug in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Effects of lamotrigine on electrically induced afterdischarge duration in anaesthetised rat, dog, and marmoset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Effect of Wy-45,727 on 24 h intragastric acidity in twenty normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Clinical use of lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Cerebrospinal fluid GABA and seizure control with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Clinical pharmacology of vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Effect of vigabatrin on epilepsy in mentally retarded patients: a 7-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Effects of vigabatrin on evoked potentials in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Vigabatrin in intractable childhood epilepsy: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Pharmacokinetics of cilazapril in patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Double-blind dose reduction study of vigabatrin in complex partial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073894009001071

10.1177/0883073894009001071

21 January 2018

Identifiers

DOI

0 references

1 reference